Tech Company Financing Transactions
TwinStrand Biosciences Funding Round
TwinStrand Biosciences closed a $16 million Series A funding round on 1/8/2020. Investors included Madrona Venture Group, Alexandria Venture Investments and Ridgeback Capital.
Transaction Overview
Company Name
Announced On
1/8/2020
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Series A
Investors
Madrona Venture Group (Lead Investor) (Terry Myerson)
Proceeds Purpose
TwinStrand says it will use the new funding to accelerate its product pipeline and support the growth of its corporate infrastructure and pharmaceutical partnerships.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
3131 Elliott Ave. 750
Seattle, WA 98121
USA
Seattle, WA 98121
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At TwinStrand Biosciences we are using Duplex Sequencing Technology to detect ultra-rare variants that are invisible by other sequencing approaches. We are applying our technology to a new generation of high-accuracy clinical diagnostics and innovative tools for scientific discovery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jesse Salk
Chief Operating Officer
Elena Cant
Vice President
Kellie Bickel
VP - General Counsel
Kissy Dabbs
VP - Marketing
Alex Lindell
VP - Sales
Brett Fritz
Browse more venture capital transactions:
Prev: 1/8/2020: Curricula venture capital transaction
Next: 1/8/2020: Sonendo venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs